Akers Biosciences Cm (AKER) 2.10 $AKER Akers Biosciences

New Post Public Reply Private Reply Replies (0) Message Board

Jun 23, 2016 at 3:23 AM

Akers Biosciences Cm (AKER) 2.10 $AKER

Akers Biosciences to Present at LD Micro Invitational Conference
Marketwire Canada - Fri Jun 03, 8:52AM CDT
THOROFARE, NJ--(Marketwired - Jun 3, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) (the "Company"

, a developer of rapid health information technologies, announces that Co-founder and Chief Scientific Director, Raymond F. Akers, Jr. PhD, will present to investors attending the upcoming LD Micro Invitational Conference in Los Angeles, CA. on Tuesday June 7, 2016. Dr. Akers intends to provide an update on the Company's business including the increasing traction in the US and China of the Company's flagship rapid test for Heparin-induced thrombocytopenia.
AKER: 2.10 (-0.03)

Akers (AKER) Reports Q1 Earnings; Product Revenue Up 79.3%
Aparajita Dutta - Zacks Investment Research - Thu May 12, 7:46AM CDT
Akers' (AKER) first-quarter product revenue increased 79.3% from the year-ago quarter to $738,023
AKER: 2.10 (-0.03)

Akers Biosciences Reports Earnings for Q1 2016
Marketwire Canada - Thu May 12, 6:00AM CDT
PIFA Heparin/PF4 Rapid Tests Sales Up 88%; Total Revenues up 45%
AKER: 2.10 (-0.03), AKR: 34.18 (-0.05)

Akers Biosciences Announces Conference Call to Discuss Q1 2016 Earnings
Marketwired - Tue May 10, 6:00AM CDT
THOROFARE, NJ--(Marketwired - May 10, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, will hold a conference call on Thursday, May 12, 2016 at 09:00 a.m. Eastern Time to discuss its earnings for the first quarter ended March 31, 2016, which will be published earlier that day. Management will be available during a question-and-answer session.
AKER: 2.10 (-0.03)

Akers Biosciences (AKER) Q1 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:52AM CDT
Akers Biosciences Inc (AKER) is expected to report first-quarter 2016 results on May 12.
CAPR: 4.27 (-0.05), STAA: 5.26 (-0.15), AKER: 2.10 (-0.03), VBLT: 3.96 (-0.03)

Akers Biosciences to Present at 'Pioneers 2016' Investor Conference
Marketwire Canada - Wed May 04, 1:00PM CDT
THOROFARE, NJ--(Marketwired - May 4, 2016) - Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR), (the "Company"

, a developer of rapid health information technologies, is presenting at Joseph Gunnar & Co., LLC's 'Pioneers 2016' conference in New York on May 5, 2016.
AKER: 2.10 (-0.03), AKR: 34.18 (-0.05)

Akers Board Rearrangement
Marketwired - Fri Apr 29, 6:01AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces changes to the roles of certain board members, which take effect immediately and are designed to improve the effectiveness of the Board of Directors.
AKER: 2.10 (-0.03)

Akers' Loss Widens in 2015, Revenues Deteriorate Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 9:46AM CDT
Akers Biosciences Inc. (AKER) reported loss of $1.81 per share in full-year 2015, much wider than 66 cents recorded in 2014.
AMZN: 710.60 (-5.22), BAX: 44.94 (-0.07), AKER: 2.10 (-0.03), HRC: 51.28 (+0.16)

Akers Biosciences Reports Earnings for Fiscal Year 2015
Marketwired - Wed Mar 30, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, reports its financial results for the fiscal year ended December 31, 2015.
AKER: 2.10 (-0.03)

What Awaits Akers Biosciences (AKER) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 8:10AM CDT
Akers Biosciences Inc (AKER) is expected to report fourth-quarter 2015 earnings results on Mar 30.
AMZN: 710.60 (-5.22), AXDX: 15.29 (-0.09), AKER: 2.10 (-0.03)

Akers Biosciences' Protein Preparation Gets Patent Cover
Zacks Equity Research - Zacks Investment Research - Thu Mar 24, 9:10AM CDT
Akers Biosciences Inc. (AKER) recently won a patent from the United States Patent and Trademark Office (USPTO) for its proprietary protein preparation.
BAX: 44.94 (-0.07), LMAT: 14.69 (+0.15), AKER: 2.10 (-0.03), HRC: 51.28 (+0.16)

Akers Biosciences Allowed US Patent for Heparin/PF4 Antibody Detection
Marketwired - Wed Mar 23, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers Bio" or the "Company"

, a developer of rapid health information technologies, announces that the United States Patent and Trademark Office has allowed a patent covering Akers Bio's proprietary methods for detecting heparin/platelet factor 4 antibodies (the "Patent"

.
AKER: 2.10 (-0.03)

Akers Biosciences Announces Conference Call to Discuss Its 2015 Earnings
Marketwired - Wed Mar 16, 6:00AM CDT
Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L) ("Akers Bio" or the "Company"

, a developer of health information technologies, will hold a conference call on Wednesday, March 30, 2016 at 09:00 a.m. Eastern Time to discuss its earnings, which will be published earlier that day, for the fiscal year ended December 31, 2015.
AKER: 2.10 (-0.03)

Akers Receives Order for Rapid Assays in China; Shares Rise
Zacks Equity Research - Zacks Investment Research - Thu Mar 03, 1:20PM CST
Shares of Akers Biosciences (AKER) rallied 11.2% (19 cents) on Mar 2, following the announcement of an order to supply PIFA Heparin PF4/Rapid Assay products in China.
ABMD: 101.70 (-0.06), AKER: 2.10 (-0.03), LMNX: 19.69 (-0.03), CRY: 11.85 (-0.15)

Akers Biosciences to Present at Disruptive Growth & Healthcare Conference
GlobeNewswire - Mon Feb 08, 11:18AM CST
Akers Biosciences, Inc. (NASDAQ:AKER) (AIM:AKR.L), ("Akers Bio" or the "Company"

, a developer of cutting edge technologies that deliver rapid health information, is presenting at Source Capital's 2016 Disruptive Growth & Healthcare conference in New York on February 10, 2016.
AKER: 2.10 (-0.03)

Akers Biosciences JV Facility Now Operational in China
Zacks Equity Research - Zacks Investment Research - Thu Dec 03, 11:50AM CST
Akers Biosciences (AKER) recently announced that its Chinese joint venture's 10000 square foot production facility is now fully operational.
ICUI: 104.98 (+0.28), AMZN: 710.60 (-5.22), NXTM: 19.38 (-0.54), AKER: 2.10 (-0.03)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Africa-Caribbean Trade Potential: A $1.65B Opportunity

Untapped Opportunities Between Africa and the Caribbean Who's ready to shake up the trade game between Africa and the Caribbean? According to a fresh-off-the-press report from the International Trade Centre (ITC) and Afreximbank, we could be looking at a whopping $1.65 billion in annual trade between these two regions by 2030. That's right, a billion with a 'B'. But let...

Speakeasy Dispensary Brings Medical Cannabis to Maysville

New Chapter for Maysville: Speakeasy Opens Doors Normally, you'd think of medical cannabis expansions as dry numbers and policies, but with Speakeasy Dispensary making its mark in Maysville, it's not just about business; it's a service to the community. Nestled into 317 W 2nd St, this is more than a simple retail spot. It's about bringing medical options straight to the...

Camect and 3Si Partnership: Revolutionizing Public Safety

Smarter Surveillance with Camect and 3Si A fresh collaboration is stirring the security pot, straight from Silicon Valley's buzzing tech nest. Camect, the brainiacs behind AI-powered video smarts, are shaking hands with 3Si Security Systems. In plain talk, they're hooking up Camect's sharp-eyed video tech with 3Si's DirectToDispatch™ system. This ain’t some techie...

Meteor Education Bolsters CTE Reach with AET Labs Buy

Meteor's Move: AET Labs Picked Up in CTE Plays You see, Meteor Education ain't sitting on its hands, that's for sure. They're out here hoarding strategic pieces like it's a chess match, snatching up AET Labs to bolster their already sturdy CTE playbook. No financial details spilled, but hell, that’s par for the course. This move plants them even more firmly in New...

Massimo Debuts 1500 UTV Line at 2026 SEMA Show

Setting the Stage at SEMA 2026 In the chaotic whirl of the 2026 SEMA Show, Massimo Group didn't just roll out new wheels—they took a leap into the big leagues. Amidst the bustling Vegas crowd, Massimo unveiled their latest babies: the Warrior 1500XD and the Sentinel 1500 HVAC Crew. These ain't just any UTVs; they're packing some serious muscle with a 1,499cc engine,...

Lupin Launches HIV Treatment, Secures 180-Day Exclusivity

Lupin's Market Move: A Big Step in HIV Treatment There's a fresh gust blowing in the pharmaceutical skies today, as Lupin leaps ahead with the launch of their Raltegravir Tablets in the U.S. The company just bagged FDA approval, putting them on the front lines with a high-stake 180-day exclusivity period for their generic version. For investors keeping tabs on pharma...

Reju Partners with Six Mills to Advance Textile Regeneration

Big Moves in Textile Regeneration Now here's a move that's got the fabric world buzzing: Reju, the scrappy textile-to-textile regenerative powerhouse, is teaming up with six mills spread across Europe and the U.S. They’re setting the stage to crank up their polyester recycling game and flood the market with sustainable, eco-friendly fabrics. It's a bold step toward...

TETRA Hits High Mark with Robust Q3 Earnings Surge

Financial Milestones and Market Insights Boy, if you're not watching TETRA Technologies (NYSE:TTI) right now, you're probably missing out on a real barnstormer of a financial report. The numbers are looking chalkboards-be-damned stellar! They’ve just notched their finest third quarter in a decade, bringing in revenues through the roof at $168 million—an impressive 10%...

Windward Expands Maritime Scope with Azimut.ai Deal

An Invincible Maritime Shield When it comes to maritime intelligence, Windward just pulled a fast one. In a market where staying ahead of the game is like playing three-dimensional chess, they've snatched up Azimut.ai. This ain't some small fry; it's a visual intelligence firm poised to shore up Windward's grip on the elusive maritime world. Charting New Waters with...

Renue Hawaii Ups Carpet Cleaning Game for Holidays

The Stakes of Carpet Care in Hawaii's Resorts Ah, Hawaii—the land of breathtaking beaches, vibrant luaus, and plush hotel carpets that take a beating every peak travel season. But before you brush off carpet care as mundane as a hollow coconut, let’s talk serious business. Renue Hawaii isn't fooling around with some one-size-fits-all cleaning routine. They’ve just...